ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 53 filers reported holding ENZO BIOCHEM INC in Q4 2022. The put-call ratio across all filers is 4.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $24,765 | -8.6% | 19,500 | 0.0% | 0.01% | -28.6% |
Q4 2023 | $27,105 | +3.0% | 19,500 | 0.0% | 0.01% | 0.0% |
Q3 2023 | $26,325 | -26.6% | 19,500 | 0.0% | 0.01% | -30.0% |
Q2 2023 | $35,880 | -24.3% | 19,500 | 0.0% | 0.01% | -23.1% |
Q1 2023 | $47,385 | +83.0% | 19,500 | +5.4% | 0.01% | +62.5% |
Q4 2022 | $25,900 | -36.8% | 18,500 | +2.8% | 0.01% | -38.5% |
Q3 2022 | $41,000 | +5.1% | 18,000 | 0.0% | 0.01% | +8.3% |
Q2 2022 | $39,000 | -26.4% | 18,000 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $53,000 | -8.6% | 18,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $58,000 | -17.1% | 18,000 | 0.0% | 0.01% | -29.4% |
Q3 2021 | $70,000 | +22.8% | 18,000 | 0.0% | 0.02% | +21.4% |
Q2 2021 | $57,000 | -8.1% | 18,000 | 0.0% | 0.01% | -17.6% |
Q1 2021 | $62,000 | +29.2% | 18,000 | 0.0% | 0.02% | +21.4% |
Q4 2020 | $48,000 | +26.3% | 18,000 | 0.0% | 0.01% | +7.7% |
Q3 2020 | $38,000 | -11.6% | 18,000 | +2.3% | 0.01% | -23.5% |
Q2 2020 | $43,000 | +2.4% | 17,600 | 0.0% | 0.02% | -22.7% |
Q1 2020 | $42,000 | -6.7% | 17,600 | +2.5% | 0.02% | +29.4% |
Q4 2019 | $45,000 | -25.0% | 17,175 | 0.0% | 0.02% | -39.3% |
Q3 2019 | $60,000 | +3.4% | 17,175 | 0.0% | 0.03% | +7.7% |
Q2 2019 | $58,000 | +23.4% | 17,175 | 0.0% | 0.03% | +18.2% |
Q1 2019 | $47,000 | -2.1% | 17,175 | 0.0% | 0.02% | -24.1% |
Q4 2018 | $48,000 | – | 17,175 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 1,105,139 | $3,072,000 | 6.35% |
HARBERT FUND ADVISORS, INC. | 1,605,000 | $4,461,000 | 4.55% |
Evermore Global Advisors, LLC | 4,527,819 | $12,587,000 | 2.06% |
CORRADO ADVISORS, LLC | 223,783 | $622,000 | 0.61% |
MARATHON CAPITAL MANAGEMENT | 332,046 | $923,000 | 0.46% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $265,000 | 0.18% |
Alambic Investment Management, L.P. | 41,097 | $114,000 | 0.05% |
ALGERT GLOBAL LLC | 58,171 | $162,000 | 0.04% |
Trivium Point Advisory, LLC | 17,175 | $48,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 61,657 | $171,000 | 0.02% |